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ABSTRACT 
A femoral artery pseudoaneurysm (FAP) is one of the most troublesome complications following invasive proce-
dures related to the femoral arterial access. Post-procedure FAP rarely occurs; however, its occurrence tends to in-
crease with the more frequently antiplatelet agents, anticoagulants, and larger-sized catheter used for interventional 
procedures. Traditionally, surgical repair has been considered as the standard treatment modality for FAP; how-
ever, less invasive methods currently exist such as blind manual or ultrasound-guided compression repair (UGCR) 
as well as percutaneous thrombin injection, both of which have replaced the need for surgery. We report a case 
of a giant pseudoaneurysm in a femoral artery, which had developed as a complication of stenting in a patient with 
carotid artery stenosis and ischemic heart disease, and was subsequently successfully treated using percutaneous 
thrombin injection. (Korean Circ J 2010;40:292-294) 
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Introduction 
 
Iatrogenic femoral artery pseudoaneurysm (IFAP) is 
an undesirable complication of invasive procedures in-
volving a femoral arterial puncture site. The incidence of 
femoral artery pseudoaneurysm (FAP) varies from 0.05-
8% following interventional procedures.
1) Ultrasound-
guided compression repair (UGCR) has replaced surgi-
cal repair of FAP as the first-line treatment in many hos-
pitals.
2) Recently percutaneous thrombin injection has 
also become popular. Here, we report the successful tr-
eatment of giant FAP, obliterated by percutaneous th-
rombin injection after failure of UGCR in a case of ca-
rotid artery stenting.   
Case 
 
A 59-year-old man was referred due to a pulsatile, ten-
der mass in the right groin as well as a swollen leg. Seven-
teen days earlier, he had undergone left carotid artery 
stenting as part of the treatment for a recent stroke via 
the right femoral artery. Ultrasound (US) confirmed a 
right FAP (Fig. 1A), sized 55×30 mm, and compression 
on the pseudoaneurysm neck was applied using a US 
probe until the flow through the neck was stopped. Re-
peated UGCR was unsuccessful resulting in enlargement 
of the FAP and discomfort to the patient which was pre-
sented as vasovagal syncope (Fig. 1B). Following this, th-
rombin (1,800 IU) was injected into the cavity of the ps-
eudoaneurysm using US guidance (Fig. 1C and D). To 
avoid distal migration of the thrombin, we occluded the 
right femoral artery intermittently during thrombin in-
jection using an angioplasty balloon (Fig. 1E). The pseu-
doaneurysm was thrombosed following the procedure. 
A one day post-operative US revealed the clotted cavity 
of the pseudoaneurysm with a small sized subcutaneous 
hematoma in the right groin area (Fig. 1F). He was dis-
charged without complication or recurrence of pseudo-
aneurysm.  
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Discussion  
 
IFAP is one of the complications related to interven-
tional procedures at the femoral artery access site. Com-
plications of pseudoaneurysm include rupture, distal em-
bolization, local pain, neuropathy, and limb ischemia.
3) 
Traditionally, surgical repair has been the main treat-
ment for FAP, especially when pseudoaneurysm larger 
than 4 cm is indicated or when anticoagulation or GP-
IIbIIIa inhibitors are extensively used during the pro-
cedure.
4) However , it has been reported that surgical 
complications occurred in 71% of cases including the 
need for transfusion (53%), infection (19%), wound de-
hiscence (12.7%) and mortality (3.8%).
5) Recently, suc-
cessful closures of pseudoaneurysms using nonsurgical 
techniques have been reported in many institutes. In 
particular, the success rate of UGCR has been report-
ed as 71-99%.
1) However, there are disadvantages of 
UGCR including long procedure times, discomfort to 
patients, and a recurrence rate as high as 25-35% in cases 
receiving anticoagulant therapy. In addition, UGCR 
was shown to be less effective in cases of FAP larger than 
3-4 cm.
3)  
On the other hand, US-guided thrombin injection 
is non-invasive, cost-effective, and has an advantage of 
decreasing the risk of post surgery morbidity. Overall 
success rates have ranged from 91% to 100% with pro-
cedure times averaging only 15 minutes.
1) Further, recurr-
ence rates have been relatively low, ranging from 0% to 
9% and have been related to obesity (body mass index 
>30) and extensively combined treatment with antico-
agulation.
1)6) The average dose of thrombin utilized in the 
A  B
C  D
E  F
Fig. 1. Color flow demonstrating blood flow in right femoral artery, through the neck into the pseudoaneurysm (A), pseudoaneurysm re-
curred after UGCR had failed (B), needle entering the pseudoaneurysm (C), coagulation of blood after thrombin injection (D), occlusion
of the right femoral artery with a balloon during the thrombin injection (E), completely obliterated neck and no blood signals within the
pseudoaneurysm from the thrombus formation (F). UGCR: ultrasound-guided compression repair.  
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literature has been approximately 1,100 IU with a range 
of 100 to 5,000 IU.
1) Side effects of thrombin injection 
have included distal embolism and immunologic cross-
reaction to human factor V.
1)7) The current case suggests 
that US-guided thrombin injection may represent a fea-
sible option in the treatment of FAP in situations where 
both manual and UGCR had failed.
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